Multiple Gastric Metastases after Distal Pancreatectomy for Pancreatic Cancer
暂无分享,去创建一个
N. Sasahira | Y. Igarashi | A. Kasuga | M. Takamatsu | Chinatsu Mori | Takashi Sasaki | Takafumi Mie | Yuto Yamada | Tsuyoshi Takeda | M. Matsuyama | M. Ozaka | Takeshi Okamoto | T. Furukawa
[1] N. Sasahira,et al. Treatment outcomes of erlotinib plus gemcitabine as late-line chemotherapy in unresectable pancreatic cancer. , 2021, Japanese journal of clinical oncology.
[2] Ying Lv,et al. Gastric metastasis from pancreatic cancer characterized by mucosal erosion: a case report and literature review , 2021, The Journal of international medical research.
[3] N. Sasahira,et al. Improved prognosis of pancreatic cancer patients with peritoneal metastasis. , 2021, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].
[4] A. Jemal,et al. Cancer Statistics, 2021 , 2021, CA: a cancer journal for clinicians.
[5] K. Koike,et al. A retrospective comparative study of S-IROX and modified FOLFIRINOX for patients with advanced pancreatic cancer refractory to gemcitabine plus nab-paclitaxel , 2020, Investigational New Drugs.
[6] N. Sasahira,et al. Modified FOLFIRINOX as a second-line therapy following gemcitabine plus nab-paclitaxel therapy in metastatic pancreatic cancer , 2020, BMC Cancer.
[7] H. Kawabata,et al. Management of Bleeding from Unresectable Gastric Cancer , 2019, Biomedicines.
[8] M. Miyazaki,et al. A case of successfully resected metachronous gastric and gallbladder metastases from pancreatic body cancer , 2019, Surgical Case Reports.
[9] H. Kocher,et al. Pancreatic Cancer , 2019, Methods in Molecular Biology.
[10] N. Sasahira,et al. Improvement of Treatment Outcomes for Metastatic Pancreatic Cancer: A Real-world Data Analysis , 2018, In Vivo.
[11] H. Baba,et al. Cystic gastric metastasis from pancreatic cancer , 2018, Surgical Case Reports.
[12] N. Sata,et al. Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01) , 2016, The Lancet.
[13] Katsumasa Nakamura,et al. A Nationwide Survey in Japan of Palliative Radiotherapy for Bleeding in Gastrointestinal and Genitourinary Tumor Patients , 2016, World journal of oncology.
[14] J. Sasajima,et al. Hematogenous Gastric Metastasis of Pancreatic Cancer , 2016, Case Reports in Gastroenterology.
[15] H. Kennecke,et al. Prognostic factors and sites of metastasis in unresectable locally advanced pancreatic cancer , 2015, Cancer medicine.
[16] David Goldstein,et al. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. , 2013, The New England journal of medicine.
[17] A. Zalatnai,et al. Pancreatic Carcinomas in a 60-Year, Institute-Based Autopsy Material With Special Emphasis of Metastatic Pattern , 2011, Pancreas.
[18] P. Murawa,et al. Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group , 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] Daniela Medeiros Milhomem Cardoso,et al. Metastatic cancer to the stomach , 2005, Gastric Cancer.
[20] H. Takamori,et al. Metastatic gastric tumor secondary to pancreatic adenocarcinoma , 2005, Journal of Gastroenterology.
[21] S. Yoshida,et al. Metastatic tumors to the stomach: analysis of 54 patients diagnosed at endoscopy and 347 autopsy cases. , 2001, Endoscopy.
[22] P. Feczko,et al. Metastatic disease involving the gastrointestinal tract. , 1993, Radiologic clinics of North America.
[23] B. Scobie. Malignant gastric ulcer due to metastasis. , 1966, Australasian radiology.